COMBINATION OF A BCL-2 INHIBITOR AND A MCL-1 INHIBITOR, USES AND PHARMACEUTICAL COMPOSITIONS THEREOF
A combination comprising a BCL-2 inhibitor and a MCL1 inhibitor, and compositions and uses thereof. L'invention concerne une combinaison comprenant un inhibiteur de BCL-2 et un inhibiteur de MCL1, ainsi que des compositions et utilisations associées.
Saved in:
Main Authors | , , , , , , , , , , , , |
---|---|
Format | Patent |
Language | English French |
Published |
25.01.2018
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | A combination comprising a BCL-2 inhibitor and a MCL1 inhibitor, and compositions and uses thereof.
L'invention concerne une combinaison comprenant un inhibiteur de BCL-2 et un inhibiteur de MCL1, ainsi que des compositions et utilisations associées. |
---|---|
AbstractList | A combination comprising a BCL-2 inhibitor and a MCL1 inhibitor, and compositions and uses thereof.
L'invention concerne une combinaison comprenant un inhibiteur de BCL-2 et un inhibiteur de MCL1, ainsi que des compositions et utilisations associées. |
Author | PORTER, Dale GENESTE, Olivier MARAGNO, Ana Leticia POMILIO, Giovanna WANG, Youzhen MISTRY, Prakash CLAPERON, Audrey MAACKE, Heiko MORRIS, Erick MOUJALLED, Donia WEI, Andrew HALILOVIC, Ensar SANGHAVI, Sneha |
Author_xml | – fullname: MARAGNO, Ana Leticia – fullname: POMILIO, Giovanna – fullname: MISTRY, Prakash – fullname: MAACKE, Heiko – fullname: GENESTE, Olivier – fullname: HALILOVIC, Ensar – fullname: WEI, Andrew – fullname: MOUJALLED, Donia – fullname: MORRIS, Erick – fullname: SANGHAVI, Sneha – fullname: CLAPERON, Audrey – fullname: WANG, Youzhen – fullname: PORTER, Dale |
BookMark | eNrjYmDJy89L5WRIcfb3dfL0cwzx9PdT8HdTcFRwcvbRNVLw9PPwdPIM8Q9ScPRzAYr6AkUNEaI6CqHBrsFguQAPxyBfR2fX0BBPZ0cfBaB5Af7BniDzghVCPFyDXP3deBhY0xJzilN5oTQ3g7Kba4izh25qQX58anFBYnJqXmpJfLi_kYGhhYGhqamRmaOhMXGqAOr5NmI |
ContentType | Patent |
DBID | EVB |
DatabaseName | esp@cenet |
DatabaseTitleList | |
Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Chemistry Sciences |
DocumentTitleAlternate | COMBINAISON D'UN INHIBITEUR DE BCL-2 ET D'UN INHIBITEUR DE MCL-1, UTILISATIONS ET COMPOSITIONS PHARMACEUTIQUES ASSOCIÉES |
ExternalDocumentID | WO2018015526A1 |
GroupedDBID | EVB |
ID | FETCH-epo_espacenet_WO2018015526A13 |
IEDL.DBID | EVB |
IngestDate | Fri Jul 19 14:42:47 EDT 2024 |
IsOpenAccess | true |
IsPeerReviewed | false |
IsScholarly | false |
Language | English French |
LinkModel | DirectLink |
MergedId | FETCHMERGED-epo_espacenet_WO2018015526A13 |
Notes | Application Number: WO2017EP68453 |
OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20180125&DB=EPODOC&CC=WO&NR=2018015526A1 |
ParticipantIDs | epo_espacenet_WO2018015526A1 |
PublicationCentury | 2000 |
PublicationDate | 20180125 |
PublicationDateYYYYMMDD | 2018-01-25 |
PublicationDate_xml | – month: 01 year: 2018 text: 20180125 day: 25 |
PublicationDecade | 2010 |
PublicationYear | 2018 |
RelatedCompanies | LES LABORATOIRES SERVIER NOVARTIS AG |
RelatedCompanies_xml | – name: NOVARTIS AG – name: LES LABORATOIRES SERVIER |
Score | 3.1333551 |
Snippet | A combination comprising a BCL-2 inhibitor and a MCL1 inhibitor, and compositions and uses thereof.
L'invention concerne une combinaison comprenant un... |
SourceID | epo |
SourceType | Open Access Repository |
SubjectTerms | HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
Title | COMBINATION OF A BCL-2 INHIBITOR AND A MCL-1 INHIBITOR, USES AND PHARMACEUTICAL COMPOSITIONS THEREOF |
URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20180125&DB=EPODOC&locale=&CC=WO&NR=2018015526A1 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3fS8MwEA5jivqmU3E6JaD0yaL9keoehrRpSyu2KbXTvY0lbUGQbriK_76X2rk97S29g6M5-C65NN9XhG5KAJEFO2O1NMRMNQXnKudkppam9UismSZILrnDUWwFY_N5QiYd9LniwjQ6oT-NOCIgSgDe66ZeL9aHWG5zt3J5xz_ANH_ys5GrtN2xJustUVxn5CXMZVShFPo2JU5bHyG6ZUOvtCM30lJp33tzJC9lsbmo-IdoN4F4VX2EOkXVQ_t09e-1HtqL2k_eMGzRtzxGOWWRE_7p12LmYxs79EXVcRgHoRNmLMV27II1Aqu2tt7iMRTNxpcEdhrZ1BtnUgYBQ7yEvYYNkxhngZd6zD9B176X0UCF153-Z2f6zjbnZpyibjWvijOEh0IY_GGY51ppmETcc60QpQb4leRUTvQ-GmyLdL7dfYEO5KM8jdDJAHXrr-_iEtbnml81af0F-iyK2g |
link.rule.ids | 230,309,786,891,25594,76903 |
linkProvider | European Patent Office |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1bS8MwFA5jivNNp-JlakDpk0V7SecehvRKq2tTaqd7G0vagiDdcBX_vqexc3vaWzgHDkngO8mX5DtB6LYAEBmwM5YLjc9knTMmM0ZmcqEbj8SYKZxktXY4jAx_rD9PyKSFPldaGFEn9EcURwREccB7JfL1Yn2I5Yi3lct79gGm-ZOXDh2pYcdKnW-J5FhDN6YOtSXbBt4mRUnjI0Q1TOBKO30ghYIsvVm1LmWxuah4B2g3hnhldYhaedlFHXv191oX7YXNlTc0G_Qtj1Bm09AK_urXYuphE1v2SFZxEPmBFaQ0wWbkgDUEq7K23uExJE3hi30zCU3bHad1GQQM8WL6GgglMU59N3Gpd4xuPDe1fRm6O_2fnek73RybdoLa5bzMTxEecK6x_iDLlELTCX9gSs4LBfBbi1MZUc9Qb1uk8-3ua9Tx03A0HQXRywXar131yYRKeqhdfX3nl7BWV-xKTPEvnYWNxA |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=COMBINATION+OF+A+BCL-2+INHIBITOR+AND+A+MCL-1+INHIBITOR%2C+USES+AND+PHARMACEUTICAL+COMPOSITIONS+THEREOF&rft.inventor=MARAGNO%2C+Ana+Leticia&rft.inventor=POMILIO%2C+Giovanna&rft.inventor=MISTRY%2C+Prakash&rft.inventor=MAACKE%2C+Heiko&rft.inventor=GENESTE%2C+Olivier&rft.inventor=HALILOVIC%2C+Ensar&rft.inventor=WEI%2C+Andrew&rft.inventor=MOUJALLED%2C+Donia&rft.inventor=MORRIS%2C+Erick&rft.inventor=SANGHAVI%2C+Sneha&rft.inventor=CLAPERON%2C+Audrey&rft.inventor=WANG%2C+Youzhen&rft.inventor=PORTER%2C+Dale&rft.date=2018-01-25&rft.externalDBID=A1&rft.externalDocID=WO2018015526A1 |